Pneumologie 2017; 71(S 01): S1-S125
DOI: 10.1055/s-0037-1598260
Freie Vorträge – Sektion Rehabilitation, Prävention und Tabakkontrolle
Highlights aus der Rehabilitation 2016 – Klaus Kenn/Schönau a.K., Konrad Schultz/Bad Reichenhall
Georg Thieme Verlag KG Stuttgart · New York

The effect of singing therapy compared to standard physiotherapeutic lung sport in COPD

S Jamaly
1  Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Bergisches Lungenzentrum
,
M Leidag
1  Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Bergisches Lungenzentrum
,
HW Schneider
2  Hustifex®-Brummer®
,
U Domanksi
3  Helios Klinik Hagen-Ambrock, Universität Witten/Herdecke, Pneumologie
,
K Rasche
1  Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Bergisches Lungenzentrum
,
M Schröder
4  Helios-Klinik Hagen Ambrock
,
G Nilius
3  Helios Klinik Hagen-Ambrock, Universität Witten/Herdecke, Pneumologie
› Author Affiliations
Further Information

Publication History

Publication Date:
23 February 2017 (online)

 

Introduction:

COPD causes adverse effects on physical and mental well-being. Non-drug treatments like physiotherapy lung exercises (PLE) improve the lifequality (LQ) and prognosis. Therapeutic Singing (TS) is a new therapy with breathing exercises and techniques. Study's aim was to compare the effect of TS with established PLE in COPD.

Methodology:

Single-center, open, prospective, randomized, pilot study with 22 patients (12 TS, 10 PLE, mean: age 63 ± 6 years, FEV1 1.65 ± 0.65 l, height 172 ± 10 cm, weight 84 ± 24 kg, exacerbation-free) participated, 8 course units (cu) each 1½hours within 4 weeks. Measuring LQ (SGRQ, CAT) before and after course, lung function (LF) had additionally after 1st cu.

Results:

LQ improved: TS: SGRQ 41 ± 20 to 31 ± 18 points (p = 0.016), CAT 17 ± 9 to 12 ± 8 points (p = 0.029); PLE: SGRQ 44 ± 12 to 37 ± 16 points (p = 0.037), CAT 19 ± 4 to 16 ± 6 points (p = 0.161). LF showed: TS FEV1 1.5 ± 0,6 l output value, no short-term effect, but 1.7 ± 0,7 l after cu in comparison to PLE with no effect; hyperinflation decreases in TS RV%/TLC 58 ± 12,3% to 51 ± 14,5% (p = 0.002).

Conclusion:

This study showed that TS has in LQ and LF comparable, even better values than the established PLE. Results need to be replicated in another test-series with more patients inclusive duration and intensity. TS may offer an additional treatment option for non-pharmacological treatments for COPD.